Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.
about
Ischemic stroke and repair: current trends in research and tissue engineering treatmentsGustatory innervation and bax-dependent caspase-2: participants in the life and death pathways of mouse taste receptor cellsMolecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic BrainTwo caspase-2 transcripts are expressed in rat hippocampus after global cerebral ischemiaProgesterone in experimental permanent stroke: a dose-response and therapeutic time-window studyAdenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils.Long-term safety of GDNF gene delivery in the retina.Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionTrophic factors and stem cells for promoting recovery in stroke.Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury.Growth factors in ischemic stroke.Magnesium sulfate and nimesulide have synergistic effects on rescuing brain damage after transient focal ischemia.Transplantation of fetal kidney cells: neuroprotection and neuroregeneration.Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning.Adult neurogenesis and the ischemic forebrain.An immortalized rat ventral mesencephalic cell line, RTC4, is protective in a rodent model of strokeThe PIDDosome mediates delayed death of hippocampal CA1 neurons after transient global cerebral ischemia in rats.Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult ratPharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.Egr-1 is necessary for fibroblast growth factor-2-induced transcriptional activation of the glial cell line-derived neurotrophic factor in murine astrocytes.Progesterone improves long-term functional and histological outcomes after permanent stroke in older rats.Gene and stem cell therapy in ischemic stroke.Biopharmaceutical drug targeting to the brain.Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and RegenerationNeuroprotection by GDNF in the ischemic brain.Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system.Tissue regeneration in stroke: cellular and trophic mechanisms.The protein and mRNA expression levels of glial cell line-derived neurotrophic factor in post stroke depression and major depressive disorder.Targeted delivery of growth factors in ischemic stroke animal models.Neuroprotective effects of GDNF-expressing human amniotic fluid cells.Antiapoptotic and antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats.Construction of targeting vector for expressing human GDNF in cattle mammary gland.Sendai virus-mediated gene transfer of GDNF reduces AIF translocation and ameliorates ischemic cerebral injury.GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier.Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia.Glial cell line-derived neurotrophic factor protects astrocytes from staurosporine- and ischemia- induced apoptosis.The first cysteine-rich domain of the receptor GFRalpha1 stabilizes the binding of GDNFPostischemic administration of Sendai virus vector carrying neurotrophic factor genes prevents delayed neuronal death in gerbils.Protection against ischemic brain damage by GDNF affecting cell survival and death signals.
P2860
Q26851602-B22BD6FB-BD9D-45C6-A43A-60AB4267D3F2Q28504724-9A9B6FCA-3C51-4D5A-8CE0-9438D5136766Q28552222-2326B0B8-AEB9-48C0-8C26-F9BCF313F62EQ28576206-005630E0-5A21-4475-A18D-AAFEC491B481Q30570937-37B15583-875E-4B76-8831-F2328F996CEAQ33186150-DBBBE1EB-280D-4FE2-B66D-03E6CF38FDA8Q33221962-A023AED2-6C72-498A-879C-45137FB60EEEQ34067458-B4B6F48E-851B-429B-BA46-F251FE47EDD9Q34088803-47A3CF88-3166-44B4-A250-FE2E9146AF12Q34240109-3B604B65-2984-4C95-A6EB-0FF9438D3CBAQ34699733-7324D374-8ED6-4871-A866-6FF1AEB430ECQ35216143-0567B74C-338C-4AFC-8F67-2EFE3AA625C7Q35908888-72EE4208-D603-4C88-84DB-2E6B1CDAEBE5Q36079544-FF65D936-F3A5-46E6-AA69-108DE214834AQ36104653-54463543-8E3E-49B2-BEE3-FB53C54AB645Q36164726-81805299-EA8E-45A7-AFF5-7213866A8DD8Q36808331-B39D399A-415E-411B-8475-4ED1BF4E29BFQ36932474-4788732D-FA9A-49A1-BBC4-334707C2FE66Q37019997-F0667C2E-C547-4135-B2A6-D9E637B3A711Q37331421-CE59CE41-7D1F-4A5F-8515-6E70C3CBE4A8Q37431824-DD5AF2E7-1C6F-4FB1-8265-748DE340AC31Q37460898-277DDDDC-4C04-47C9-8A91-0067F889350FQ37517939-02321E9D-B7FB-486D-A552-D837583F030BQ37671828-7892FB70-15DE-42D9-AC34-6F0365C80A87Q37702284-AD8E2A60-ABF9-44E9-A78A-315DBC0DC115Q38016480-B98EB9A5-C060-415B-A425-47B58C963F72Q38137175-F019AB3A-24F6-463D-9DCA-9717D3990852Q38227799-A9C1E36F-471C-4D31-9FBF-7A34C304F578Q38694667-B20156A2-5873-4814-989D-EAD131E62FA8Q38703863-4938C79B-1DAB-49F7-8DE7-CE41164B5FA4Q39035207-09DAED7D-17D5-4285-B4DA-4F7DA0ADF9E8Q39736710-198DF488-B6E1-4BD9-967F-E5EBC04E7A46Q39887339-5F855A3C-3CE4-4562-89DB-F244FC004DAEQ39966520-17F701FA-B186-4EAB-983F-DC9AA95A3162Q40035420-2A977694-C43F-4E23-B0F4-C69DB22B44F4Q40078558-2C5EB019-B791-4814-9B55-122A96342CCDQ40133765-9DA7B194-6635-4483-AEFD-86808136058DQ40478918-9AF6C044-75BE-40BD-BE77-4CF3FFA04F04Q40590314-C9AE7AA2-428A-4428-A9F6-5D4242FAC6F3Q40648835-1F3DD0A7-F378-4FAA-968C-36FA628AAB5E
P2860
Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Reduction of ischemic brain in ...... bral artery occlusion in rats.
@en
type
label
Reduction of ischemic brain in ...... bral artery occlusion in rats.
@en
prefLabel
Reduction of ischemic brain in ...... bral artery occlusion in rats.
@en
P2093
P356
P1433
P1476
Reduction of ischemic brain in ...... bral artery occlusion in rats.
@en
P2093
P304
P356
10.1161/01.STR.29.7.1417
P407
P577
1998-07-01T00:00:00Z